IGC Pharma, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
IGC Pharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • IGC Pharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$1.72M, a 29.9% increase year-over-year.
  • IGC Pharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$12.6M, a 16.3% decline year-over-year.
  • IGC Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$13M, a 13% decline from 2022.
  • IGC Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$11.5M, a 23.4% increase from 2021.
  • IGC Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$15M, a 70.4% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$12.6M -$1.72M +$734K +29.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$13.3M -$2.38M -$303K -14.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$13M -$2.89M +$1.15M +28.4% Jan 1, 2024 Mar 31, 2024 10-K 2024-06-24
Q4 2023 -$14.1M -$5.59M -$3.34M -149% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-14
Q3 2023 -$10.8M -$2.45M -$9K -0.37% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$10.8M -$2.08M +$710K +25.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$11.5M -$4.03M +$2.47M +38% Jan 1, 2023 Mar 31, 2023 10-K 2024-06-24
Q4 2022 -$14M -$2.25M +$132K +5.54% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
Q3 2022 -$14.1M -$2.44M +$1.9M +43.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$16M -$2.79M -$997K -55.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$15M -$6.5M -$3.55M -121% Jan 1, 2022 Mar 31, 2022 10-K 2023-07-07
Q4 2021 -$11.5M -$2.38M -$58K -2.5% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-14
Q3 2021 -$11.4M -$4.34M -$2.69M -162% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 -$8.72M -$1.79M +$94K +5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 -$8.81M -$2.95M +$205K +6.5% Jan 1, 2021 Mar 31, 2021 10-K 2022-06-23
Q4 2020 -$9.02M -$2.32M -$720K -44.9% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-10
Q3 2020 -$8.3M -$1.66M -$478K -40.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 -$7.82M -$1.88M -$503K -36.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$7.32M -$3.15M -$1.58M -99.9% Jan 1, 2020 Mar 31, 2020 10-K 2021-06-14
Q4 2019 -$5.74M -$1.6M -$455K -39.6% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-16
Q3 2019 -$5.28M -$1.18M -$320K -37.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-20
Q2 2019 -$4.96M -$1.38M -$867K -169% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-19
Q1 2019 -$4.1M -$1.58M -$1.06M -205% Jan 1, 2019 Mar 31, 2019 10-K 2020-07-13
Q4 2018 -$3.04M -$1.15M -$615K -116% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-10
Q3 2018 -$2.42M -$859K -$555K -183% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$1.87M -$512K -$79.9K -18.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$1.79M -$517K +$271K +34.4% Jan 1, 2018 Mar 31, 2018 10-K 2019-06-14
Q4 2017 -$2.06M -$533K -$421K -377% Oct 1, 2017 Dec 31, 2017 10-Q 2018-02-20
Q3 2017 -$1.64M -$304K +$280K +47.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-16
Q2 2017 -$1.92M -$432K -$48.6K -12.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 -$1.87M -$788K +$611K +43.7% Jan 1, 2017 Mar 31, 2017 10-K 2018-06-21
Q4 2016 -$2.48M -$112K +$291K +72.3% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-20
Q3 2016 -$2.77M -$584K +$39.5K +6.34% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-17
Q2 2016 -$2.81M -$384K -$867 -0.23% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-18
Q1 2016 -$2.81M -$1.4M +$536K +27.7% Jan 1, 2016 Mar 31, 2016 10-K 2017-07-14
Q4 2015 -$3.34M -$403K +$187K +31.7% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-21
Q3 2015 -$3.53M -$623K +$264K +29.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-21
Q2 2015 -$3.8M -$383K +$819K +68.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-16
Q1 2015 -$4.61M -$1.94M -$472K -32.2% Jan 1, 2015 Mar 31, 2015 10-K 2016-07-14
Q4 2014 -$4.14M -$590K -$280K -90.1% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-16
Q3 2014 -$3.86M -$887K -$272K -44.2% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$3.59M -$1.2M -$568K -89.7% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$3.02M -$1.46M +$429K +22.7% Jan 1, 2014 Mar 31, 2014 10-K 2015-07-14
Q4 2013 -$3.45M -$310K -$621K -200% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-12
Q3 2013 -$2.83M -$615K -$472K -331% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$2.36M -$633K -$105K -19.9% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$2.25M -$1.89M +$2.3M +54.9% Jan 1, 2013 Mar 31, 2013 10-K 2014-07-15
Q4 2012 -$4.55M $311K +$2.21M Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q3 2012 -$6.76M -$143K +$647K +81.9% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 -$7.41M -$528K +$341K +39.2% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-16
Q1 2012 -$7.75M -$4.19M +$12.9M +75.4% Jan 1, 2012 Mar 31, 2012 10-K/A 2014-07-15
Q4 2011 -$20.6M -$1.9M -$152K -8.71% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-13
Q3 2011 -$20.5M -$789K +$67K +7.83% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$20.5M -$869K -$278K -47% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-08-21
Q1 2011 -$20.2M -$17M Jan 1, 2011 Mar 31, 2011 10-K 2012-07-16
Q4 2010 -$1.75M Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-16
Q3 2010 -$856K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-18
Q2 2010 -$591K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.